Neuron23 and QIAGEN to collaborate on diagnostic for novel Parkinson’s drug
Neuron23 Inc. and QIAGEN are to collaborate to develop a companion diagnostic for Neuron23's LRRK2…
Neuron23 Inc. and QIAGEN are to collaborate to develop a companion diagnostic for Neuron23's LRRK2…
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
Astellas Pharma Inc., Seagen Inc. and Merck (known as MSD outside of the U.S. and…
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…
OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K.…
Manufacturing partner, Lonza, has today (September 6) announced a collaboration with Touchlight, a biotech company…
Dutch biotech Synaffix B.V. and German Emergence Therapeutics announced today (September 6) they have entered…
CellOrigin Biotech (Hangzhou) Co., Ltd. and Qilu Pharmaceutical are to collaborate on strategic global collaborations…
Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral…
A phase 3 clinical trial for an injection to treat patients with schizophrenia has been…
A license agreement has been signed between Helsinn Group and Juniper Biologics further widening the…
Ensysce Biosciences, Inc., a clinical-stage biotech company, and Quotient Sciences, a drug development and manufacturing…